Author:
Hu Liping,Shi Shengmin,Song Xiaomeng,Ma Fangli,Ji Oulian,Qi Baohui
Funder
Guizhou Provincial Science and Technology Department
Science and Technology Program of Guizhou Province
National Natural Science Foundation of China
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference33 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021
2. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis;Zhang;Oncotarget,2016
3. A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives;Russo;Oncotarget,2015
4. A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy, Bioorg;Ayati;Chem,2020
5. Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance;Patel;Eur. J. Med. Chem.,2017